Alimera Sciences Inc (ALIM) Inventory Turnover Ratio, from second quarter 2024 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Alimera Sciences Inc  (NASDAQ: ALIM)
 

Alimera Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2024, Alimera Sciences Inc's inventory turnover ratio sequentially decreased to 5.84 in the second quarter 2024, otherwise the ratio remained above the average, as ALIM's markets remain strong.Alimera Sciences Inc's average inventory processing period in the Jun 30 2024 quarter, has increased to 63 days, from 52 days, in the Mar 31 2024 quarter.

Within Healthcare sector 59 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2024, to 343, from total ranking in the first quarter 2024 at 384.

ALIM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Alimera Sciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALIM Inventory Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Inventory Growth 227.49 % 81.56 % 17.07 % -1.46 % -36.29 %
Y / Y Cost of Sales Growth 57.98 % 65.34 % 70.64 % 37.49 % 11.96 %
Inventory Turnover Ratio (TTM) 5.84 7.05 7.34 6.63 6.07
ALIM's Total Ranking # 343 # 384 # 302 # 256 # 653
Average inventory processing period 63 52 50 55 60
Seq. Inventory Growth 56.62 % 17.4 % 6.76 % 66.82 % -13.17 %
Seq. Cost of Sales Growth 14.26 % -7.53 % 31.47 % 13.73 % 19.58 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 60
Overall Market # 343

Inventory Turnover Ratio Statistics
High Average Low
7.34 2.9 0.01
(Dec 31 2023)   (Jun 30 2013)



ALIM Company Profile >> Back to ALIM Efficiency Comparisons >> Compare ALIM Inventory Turnover Ratio to its Competitors

Financial Statements
Alimera Sciences Inc's Inventories $ 3 Millions Visit ALIM's Balance sheet
Alimera Sciences Inc's Cost of Revenues TTM $ 14 Millions Visit ALIM's Income Statement
What are ALIM's Sales? Visit ALIM's Sales by Segment

Other Inventory Turnover Ratios
Alimera Sciences Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ALIM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ALIM's Competitors
Inventory Turnover Ratio for ALIM's Suppliers
Inventory Turnover Ratio for ALIM's Customers

You may also want to know
ALIM's Sales Growth Rates ALIM's Pe Price to earnings ratio ALIM's Receivables Turnover Ratio ALIM's Stock Quote
ALIM's Net Income Growth Rates ALIM's Ps Price to Sales ratio ALIM's Sales per Employee ALIM's Asset Turnover Ratio
ALIM's Net Margin ALIM's Pb Price to Book ratio ALIM's Financial Strength Ratios ALIM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
Genedx Holdings Corp   10.69 $ 107.097  Millions$ 10  Millions
Novavax inc   10.55 $ 359.356  Millions$ 34  Millions
Acadia Pharmaceuticals Inc   10.34 $ 73.693  Millions$ 7  Millions
Cryo cell International Inc   10.22 $ 8.417  Millions$ 1  Millions
Infusystem Holdings Inc  10.18 $ 65.104  Millions$ 6  Millions
Myriad Genetics Inc   10.15 $ 248.200  Millions$ 24  Millions
Sotera Health Company  10.07 $ 491.913  Millions$ 49  Millions
Moderna Inc   9.78 $ 3,381.000  Millions$ 346  Millions
Vanda Pharmaceuticals Inc   9.52 $ 12.696  Millions$ 1  Millions
Prosomnus Inc   9.32 $ 16.742  Millions$ 2  Millions
Agape Atp Corporation  9.17 $ 0.493  Millions$ 0  Millions
Mangoceuticals Inc   9.10 $ 0.156  Millions$ 0  Millions
Bioaffinity Technologies Inc   8.91 $ 0.151  Millions$ 0  Millions
Star Equity Holdings Inc   8.43 $ 38.300  Millions$ 5  Millions
Agile Therapeutics Inc  8.28 $ 30.397  Millions$ 4  Millions
Puma Biotechnology Inc   8.16 $ 58.993  Millions$ 7  Millions
Inogen Inc   7.94 $ 187.623  Millions$ 24  Millions
Lantheus Holdings Inc   7.81 $ 509.239  Millions$ 65  Millions
National Vision Holdings Inc   7.81 $ 878.649  Millions$ 113  Millions
Carlisle Companies Incorporated  7.79 $ 3,080.800  Millions$ 396  Millions
23andme Holding Co  7.54 $ 109.000  Millions$ 14  Millions
Bionexus Gene Lab Corp   7.26 $ 7.909  Millions$ 1  Millions
Charles River Laboratories International inc   7.20 $ 2,491.528  Millions$ 346  Millions
Kewaunee Scientific Corporation  7.14 $ 149.000  Millions$ 21  Millions
Castle Biosciences Inc   7.10 $ 52.155  Millions$ 7  Millions
Eton Pharmaceuticals Inc   6.96 $ 11.042  Millions$ 2  Millions
Collegium Pharmaceutical Inc   6.95 $ 218.115  Millions$ 31  Millions
Lifemd Inc   6.92 $ 19.000  Millions$ 3  Millions
Hims and Hers Health Inc   6.64 $ 190.655  Millions$ 29  Millions
Scienture Holdings Inc   6.55 $ 4.974  Millions$ 1  Millions

Date modified: 2026-06-22T14:32:38+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.